Gsk (GSK) EBT Margin (2009 - 2026)
Gsk (GSK) reported EBT Margin of 21.77% for the quarter ended Sep 30, 2026, down 6.96 percentage points from 28.74% a year earlier but up 17.56 percentage points from the prior quarter.
Powered by 
Analysis
Gsk (GSK) EBT Margin (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Gsk's EBT Margin came in at 20.54%, down 1.35 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at 22.66%, up 11.57 percentage points from the prior year.
- EBT Margin has a five-year change of +1.43 percentage points (years ended Dec 2020 to Dec 2025).
- By year, EBT Margin came in at 11.08% in the year ended Dec 31, 2024 (-8.91 pp), 19.99% in the year ended Dec 31, 2023 (+0.80 pp), 19.19% in the year ended Dec 31, 2022 (+4.62 pp) and 14.57% in the year ended Dec 31, 2021 (-6.66 pp).
- Five-year quarterly EBT Margin spans a low of 0.80% in the quarter ended Sep 30, 2024 and a high of 29.12% in the quarter ended Mar 31, 2022.
- Year over year, EBT Margin gained in six of the last eight quarters, with an average year-over-year change of +4.23 percentage points.
- The high point for year-over-year EBT Margin in five years was the quarter ended Sep 30, 2025 (a gain of 27.94 percentage points); the low point was the quarter ended Sep 30, 2024 (a drop of 21.18 percentage points).
- Per Business Quant data, the three quarters before the quarter ended Sep 30, 2026 came in at 4.21% (quarter ended Jun 30, 2026), 28.10% (quarter ended Mar 31, 2026) and 22.66% (quarter ended Dec 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,267.78 Bn | 1,241.40 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 659.28 Bn | 579.14 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 514.51 Bn | 482.52 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 367.42 Bn | 321.80 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 319.10 Bn | 292.34 Bn | - | - |
| 6 | Astrazeneca | 293.31 Bn | 267.20 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 258.69 Bn | 214.09 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 216.51 Bn | 191.61 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 174.99 Bn | 121.63 Bn | 10.94 Bn | -4.34% |
| 10 | Gsk | 103.65 Bn | 86.50 Bn | 8.73 Bn | 21.77% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 21.77% |
| Jun 30, 2026 | 4.21% |
| Mar 31, 2026 | 28.10% |
| Dec 31, 2025 | 22.66% |
| Sep 30, 2025 | 28.74% |
| Jun 30, 2025 | 23.63% |
| Mar 31, 2025 | 28.05% |
| Dec 31, 2024 | 6.94% |
| Sep 30, 2024 | 0.80% |
| Jun 30, 2024 | 18.96% |
| Mar 31, 2024 | 18.40% |
| Dec 31, 2023 | 4.71% |
| Sep 30, 2023 | 21.98% |
| Jun 30, 2023 | 27.68% |
| Mar 31, 2023 | 27.43% |
| Dec 31, 2022 | 22.04% |
| Sep 30, 2022 | 12.93% |
| Jun 30, 2022 | 12.93% |
| Mar 31, 2022 | 29.12% |
| Dec 31, 2021 | 4.28% |
API Access
Gsk EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();